Skip to content

OrbiMed Capital GP VIII LLC, Director at Scribe Therapeutics, bought SCTX on Jul 27, 2026

Data as of Oct 16

▲ BUY$15M1,000,000 shares at $15.00OrbiMed Capital GP VIII LLC DirectorSCTX Scribe Therapeutics, Inc.
Watch SCTX
Traded
Jul 27, 2026
Disclosed
Jul 29, 2026
Filed
2 days after the trade

Form 4s are due within two business days.

Official filing (SEC Form 4) ↗

The price around the disclosure

OrbiMed Capital GP VIII LLC, Director at Scribe Therapeutics, bought SCTX on Jul 27, 2026TRADEDDISCLOSED
SCTXSimilar stocks (XLV — its sector index fund), rebased to SCTX's price on the disclosure day
SCTX since disclosure
+9.4%
Similar stocks (XLV) since disclosure
+6.3%
XLV — its sector index fund

Change in closing price from Jul 29, 2026 (the first trading day on or after disclosure) to Oct 16, 2026. Dividends excluded. Not a return anyone earned.

Our take

None of our tested rules fired on this trade.

Other trades in the same filing

  1. ▲ BUYOrbimed Advisors LLC DirectorSCTX Scribe Therapeutics, Inc.$15Mdisclosed Jul 29 · filed 2 days after the trade

See every trade on SCTX →